Zentalis Pharmaceuticals Inc (ZNTL)

Finanzdaten der Zentalis Pharmaceuticals Inc-Aktie (ZNTL)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	17.27%44.39	37.86	37.39	33.73	36.06
Research and Development	22.45%35.16	28.72	29.49	22.95	27.61
Operating Income/Loss	17.27%-44.39	-37.86	-37.39	-33.73	-36.06
Income/Loss From Continuing Operations Before Tax	19.63%-42.15	-35.23	-34.77	-26.69	-26.87
Income Tax Expense/Benefit	15.00%0.14	0.12	0.44	-	-
	19.61%-42.29	-35.35	-35.22	-26.69	-26.87
Attributable To Parent	19.61%-42.29	-35.35	-35.22	-26.69	-26.87
Basic Average Shares	1.51%71.33	70.26	-	72.14	71.99
Diluted Average Shares	1.51%71.33	70.26	-	72.14	71.99
Basic Earnings Per Share	18.00%-0.59	-0.50	-	-0.37	-0.37
Diluted Earnings Per Share	18.00%-0.59	-0.50	-	-0.37	-0.37